The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of patents and technology to allow other producers around the word to manufacture GLP-1s, to help expand access to these…
Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICO
